Evidence map›Paper›PMID 20421379›Full record

ArticleInfection and immunity2010

Optimal CD8 T-cell response against Encephalitozoon cuniculi is mediated by Toll-like receptor 4 upregulation by dendritic cells.

Elizabeth M Lawlor, Magali M Moretto, Imtiaz A Khan

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Immune Response to Microsporidia.Experientia supplementum (2012) · 2022
    Article
  4. Review
  5. Complex and Multilayered Role of IL-21 Signaling during Thymic Development.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elizabeth M LawlorDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC 20037, USA.
Magali M Moretto
Imtiaz A Khan
George Washington University · US

Funding

ENCEPHALITOZOAN CUNICULI--HOST IMMUNITY AND PATHOGENESISR01AI043693 · NIAID · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI KHAN, IMTIAZ AHMED · 1998 to 2008
$2.5M
NIAID NIH HHS AI 043693NIAID NIH HHS R01 AI043693
6 · The paper itself

Abstract

CD8+ T-cell immunity has been shown to play an important role in the protective immune response against Encephalitozoon cuniculi. Although earlier studies suggest that dendritic cells (DC) are important for the induction of this response, the factors responsible for initiation of the dendritic cell response against this pathogen have not been evaluated. In the current study, we demonstrate that E. cuniculi infection causes strong Toll-like receptor 4 (TLR4)-dependent dendritic cell activation and a blockade of this molecule reduces the ability of DC to prime an antigen-specific CD8+ T-cell response. Pretreatment of DC with anti-TLR4 antibody causes a defect in both in vitro and in vivo CD8+ T-cell priming. These findings, for the first time, emphasize the contribution of TLR4 in the induction of CD8+ T-cell immunity against E. cuniculi infection.

Indexed as

AnimalsAutoantibodiesCD8-Positive T-LymphocytesDendritic CellsEncephalitozoon cuniculiEncephalitozoonosisGene Expression Regulation, FungalImmunity, CellularImmunoprecipitationInterleukin-12Lymphocyte ActivationMiceMice, Inbred C57BLToll-Like Receptor 4Up-RegulationAutoantibodiesInterleukin-12Toll-Like Receptor 4

Identifiers

PMID20421379
PMCPMC2897398
OpenAlexW2149655890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.